The announcement was made by Mr N Scott Fine, chairman, GVN Board of Directors, joined by Mr Robert C Gallo, MD, GVN co-founder and director of the GVN Center of Excellence, at the Institute of Human Virology, at the University of Maryland School of Medicine; Dr William Hall, MD, PhD, GVN co-founder and director of the GVN Center of Excellence, at the University College Dublin; and GVN president Dr Sharon Hrynkow, PhD.
"It is an honor and privilege to join the GVN board of directors at this pivotal point in time," said Dr Moopen.
"Collaboration among the public and private sectors is essential as we work as a global community to stem the spread of deadly diseases. I look forward to working with the board and the GVN centers of excellence to stop viral diseases in their tracks," he added.
Dr Azad Moopen, a physician-turned entrepreneur and philanthropist from Kerala, is the CMD of Aster DM Healthcare, a healthcare conglomerate in the Middle East and India with more than 200 network units inclusive of hospitals, medical centers, pharmacies, diagnostics and specialty centers, healthcare consultancy service, academics & research to a medical college and an advanced medical city.
Joining GVN as a senior advisor is Dr M V Pillai, MD, a professor of medicine at Thomas Jefferson University, and chairman of oncology at Aster MedCity, among his other leadership roles.
"I look forward to working closely with GVN to strengthen ties in research and training of virologists in Kerala, India and later across the country," said Dr Pillai.
